- Exchange: NASDAQ GM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Savient Pharmaceuticals Inc
+ Add to WatchlistSVNT:US
0.5600 USD 0.0100 1.75%As of 20:10:00 ET on 05/17/2013.
Snapshot for Savient Pharmaceuticals Inc (SVNT)
| Open: | 0.5600 | Day's Range: | 0.5110 - 0.5988 | Volume: | 2,305,689 |
|---|---|---|---|---|---|
| Previous Close: | 0.5600 | 52wk Range: | 0.4831 - 2.9500 | 1-Yr Rtn: | -34.33% |
Key Statistics for SVNT
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -1.8300 |
| Est. EPS (USD) (12/2013) | -1.1000 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 41.22 |
| Shares Outstanding (M) | 73.61 |
| 30 Day Average Volume | 390,496 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | 2.0762 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/08/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SVNT
Company Profile & Key Executives for SVNT
Savient Pharmaceuticals Inc. develops, manufactures, and markets human health care products for niche and wider markets. The Company offers pharmaceutical products for a wide range of medical needs such as weight gain, drugs targeting the control of elevated uric acid levels in the blood, and rheumatology.
| Richard P Crowley "Rick"Exec VP/COO | Louis FerrariPresident/CEO |
| John P HamillSenior VP/CFO/Treasurer | Kenneth M BahrtSenior VP/Chief Medical Ofcr |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SVNT News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page